HEADER ONCOPROTEIN,UNKNOWN FUNCTION 13-JUN-11 3SF8 TITLE STRUCTURAL INSIGHTS INTO THIOL STABILIZATION OF DJ-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN DJ-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ONCOGENE DJ1, PARKINSON DISEASE PROTEIN 7; COMPND 5 EC: 3.4.-.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROTEIN DJ-1; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: ONCOGENE DJ1, PARKINSON DISEASE PROTEIN 7; COMPND 11 EC: 3.4.-.-; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: PARK7; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDATIVE STRESS, REDOX REGULATION, CYSTEINE OXIDATION, PROTECTING KEYWDS 2 DJ-1 OXIDATION, REDUCED DJ-1, CLASS I GLUTAMINE AMIDOTRANSFERASE KEYWDS 3 FAMILY, CYTOPROTECTIVE ACTIVITY AGAINST OXIDATIVE STRESS; CYSTEINE KEYWDS 4 SULFENIC ACID MODIFICATION, HYDROLASE, ONCOPROTEIN, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR L.PREMKUMAR,M.K.DOBACZEWSKA,S.J.RIEDL REVDAT 4 06-DEC-23 3SF8 1 REMARK REVDAT 3 13-SEP-23 3SF8 1 SEQADV LINK REVDAT 2 23-NOV-11 3SF8 1 JRNL REVDAT 1 05-OCT-11 3SF8 0 JRNL AUTH L.PREMKUMAR,M.K.DOBACZEWSKA,S.J.RIEDL JRNL TITL IDENTIFICATION OF AN ARTIFICIAL PEPTIDE MOTIF THAT BINDS AND JRNL TITL 2 STABILIZES REDUCED HUMAN DJ-1. JRNL REF J.STRUCT.BIOL. V. 176 414 2011 JRNL REFN ISSN 1047-8477 JRNL PMID 21893204 JRNL DOI 10.1016/J.JSB.2011.08.011 REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 42954 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2318 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.56 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.60 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2980 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.54 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 154 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2777 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 341 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51000 REMARK 3 B22 (A**2) : 1.40000 REMARK 3 B33 (A**2) : -1.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.73000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.094 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.071 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.058 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2920 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3964 ; 1.421 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 408 ;12.185 ; 5.049 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;41.738 ;25.514 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 545 ;13.786 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;17.019 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 468 ; 0.108 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2149 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1922 ; 1.888 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3092 ; 3.194 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 998 ; 4.418 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 859 ; 7.041 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2920 ; 2.588 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3SF8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000066129. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47218 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.530 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.25200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1PDV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 45% (V/V) POLYPROYLENE GLYCOL 400, 0.1 REMARK 280 M BIS-TRIS, PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.94000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.91550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.94000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.91550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 465 ASP B 189 REMARK 465 LEU B 190 REMARK 465 GLU B 191 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 66 C - N - CA ANGL. DEV. = 15.6 DEGREES REMARK 500 PRO A 66 C - N - CD ANGL. DEV. = -14.6 DEGREES REMARK 500 PRO A 66 N - CA - C ANGL. DEV. = 16.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 67 142.00 68.34 REMARK 500 CSO A 106 -110.57 76.73 REMARK 500 CYS B 106 -105.65 75.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 65 PRO A 66 126.32 REMARK 500 REMARK 500 REMARK: NULL DBREF 3SF8 A 1 189 UNP Q99497 PARK7_HUMAN 1 189 DBREF 3SF8 B 1 189 UNP Q99497 PARK7_HUMAN 1 189 SEQADV 3SF8 LEU A 190 UNP Q99497 EXPRESSION TAG SEQADV 3SF8 GLU A 191 UNP Q99497 EXPRESSION TAG SEQADV 3SF8 LEU B 190 UNP Q99497 EXPRESSION TAG SEQADV 3SF8 GLU B 191 UNP Q99497 EXPRESSION TAG SEQRES 1 A 191 MET ALA SER LYS ARG ALA LEU VAL ILE LEU ALA LYS GLY SEQRES 2 A 191 ALA GLU GLU MET GLU THR VAL ILE PRO VAL ASP VAL MET SEQRES 3 A 191 ARG ARG ALA GLY ILE LYS VAL THR VAL ALA GLY LEU ALA SEQRES 4 A 191 GLY LYS ASP PRO VAL GLN CYS SER ARG ASP VAL VAL ILE SEQRES 5 A 191 CYS PRO ASP ALA SER LEU GLU ASP ALA LYS LYS GLU GLY SEQRES 6 A 191 PRO TYR ASP VAL VAL VAL LEU PRO GLY GLY ASN LEU GLY SEQRES 7 A 191 ALA GLN ASN LEU SER GLU SER ALA ALA VAL LYS GLU ILE SEQRES 8 A 191 LEU LYS GLU GLN GLU ASN ARG LYS GLY LEU ILE ALA ALA SEQRES 9 A 191 ILE CSO ALA GLY PRO THR ALA LEU LEU ALA HIS GLU ILE SEQRES 10 A 191 GLY PHE GLY SER LYS VAL THR THR HIS PRO LEU ALA LYS SEQRES 11 A 191 ASP LYS MET MET ASN GLY GLY HIS TYR THR TYR SER GLU SEQRES 12 A 191 ASN ARG VAL GLU LYS ASP GLY LEU ILE LEU THR SER ARG SEQRES 13 A 191 GLY PRO GLY THR SER PHE GLU PHE ALA LEU ALA ILE VAL SEQRES 14 A 191 GLU ALA LEU ASN GLY LYS GLU VAL ALA ALA GLN VAL LYS SEQRES 15 A 191 ALA PRO LEU VAL LEU LYS ASP LEU GLU SEQRES 1 B 191 MET ALA SER LYS ARG ALA LEU VAL ILE LEU ALA LYS GLY SEQRES 2 B 191 ALA GLU GLU MET GLU THR VAL ILE PRO VAL ASP VAL MET SEQRES 3 B 191 ARG ARG ALA GLY ILE LYS VAL THR VAL ALA GLY LEU ALA SEQRES 4 B 191 GLY LYS ASP PRO VAL GLN CYS SER ARG ASP VAL VAL ILE SEQRES 5 B 191 CYS PRO ASP ALA SER LEU GLU ASP ALA LYS LYS GLU GLY SEQRES 6 B 191 PRO TYR ASP VAL VAL VAL LEU PRO GLY GLY ASN LEU GLY SEQRES 7 B 191 ALA GLN ASN LEU SER GLU SER ALA ALA VAL LYS GLU ILE SEQRES 8 B 191 LEU LYS GLU GLN GLU ASN ARG LYS GLY LEU ILE ALA ALA SEQRES 9 B 191 ILE CYS ALA GLY PRO THR ALA LEU LEU ALA HIS GLU ILE SEQRES 10 B 191 GLY PHE GLY SER LYS VAL THR THR HIS PRO LEU ALA LYS SEQRES 11 B 191 ASP LYS MET MET ASN GLY GLY HIS TYR THR TYR SER GLU SEQRES 12 B 191 ASN ARG VAL GLU LYS ASP GLY LEU ILE LEU THR SER ARG SEQRES 13 B 191 GLY PRO GLY THR SER PHE GLU PHE ALA LEU ALA ILE VAL SEQRES 14 B 191 GLU ALA LEU ASN GLY LYS GLU VAL ALA ALA GLN VAL LYS SEQRES 15 B 191 ALA PRO LEU VAL LEU LYS ASP LEU GLU MODRES 3SF8 CSO A 106 CYS S-HYDROXYCYSTEINE HET CSO A 106 7 HETNAM CSO S-HYDROXYCYSTEINE FORMUL 1 CSO C3 H7 N O3 S FORMUL 3 HOH *341(H2 O) HELIX 1 1 GLU A 15 ALA A 29 1 15 HELIX 2 2 LEU A 58 LYS A 62 1 5 HELIX 3 3 LYS A 63 GLY A 65 5 3 HELIX 4 4 GLY A 75 GLU A 84 1 10 HELIX 5 5 SER A 85 ARG A 98 1 14 HELIX 6 6 PRO A 109 HIS A 115 1 7 HELIX 7 7 HIS A 126 LEU A 128 5 3 HELIX 8 8 ALA A 129 MET A 134 1 6 HELIX 9 9 GLY A 157 GLY A 159 5 3 HELIX 10 10 THR A 160 GLY A 174 1 15 HELIX 11 11 GLY A 174 ALA A 183 1 10 HELIX 12 12 PRO A 184 VAL A 186 5 3 HELIX 13 13 GLU B 15 ALA B 29 1 15 HELIX 14 14 LEU B 58 LYS B 63 1 6 HELIX 15 15 GLY B 75 SER B 85 1 11 HELIX 16 16 SER B 85 ARG B 98 1 14 HELIX 17 17 GLY B 108 HIS B 115 1 8 HELIX 18 18 HIS B 126 LEU B 128 5 3 HELIX 19 19 ALA B 129 ASN B 135 1 7 HELIX 20 20 GLY B 157 GLY B 159 5 3 HELIX 21 21 THR B 160 GLY B 174 1 15 HELIX 22 22 GLY B 174 ALA B 183 1 10 HELIX 23 23 PRO B 184 VAL B 186 5 3 SHEET 1 A 7 ALA A 56 SER A 57 0 SHEET 2 A 7 LYS A 32 GLY A 37 1 N GLY A 37 O ALA A 56 SHEET 3 A 7 ARG A 5 LEU A 10 1 N LEU A 10 O ALA A 36 SHEET 4 A 7 VAL A 69 LEU A 72 1 O VAL A 71 N LEU A 7 SHEET 5 A 7 LEU A 101 ILE A 105 1 O ALA A 103 N LEU A 72 SHEET 6 A 7 ILE A 152 SER A 155 1 O LEU A 153 N ILE A 102 SHEET 7 A 7 VAL A 146 ASP A 149 -1 N GLU A 147 O THR A 154 SHEET 1 B 4 VAL A 44 GLN A 45 0 SHEET 2 B 4 VAL A 51 CYS A 53 -1 O ILE A 52 N VAL A 44 SHEET 3 B 4 VAL B 51 CYS B 53 -1 O VAL B 51 N CYS A 53 SHEET 4 B 4 VAL B 44 GLN B 45 -1 N VAL B 44 O ILE B 52 SHEET 1 C 2 LYS A 122 VAL A 123 0 SHEET 2 C 2 THR A 140 TYR A 141 1 O THR A 140 N VAL A 123 SHEET 1 D 7 ALA B 56 SER B 57 0 SHEET 2 D 7 LYS B 32 GLY B 37 1 N GLY B 37 O ALA B 56 SHEET 3 D 7 ARG B 5 LEU B 10 1 N LEU B 10 O ALA B 36 SHEET 4 D 7 VAL B 69 LEU B 72 1 O VAL B 71 N LEU B 7 SHEET 5 D 7 LEU B 101 ILE B 105 1 O ALA B 103 N LEU B 72 SHEET 6 D 7 ILE B 152 SER B 155 1 O LEU B 153 N ILE B 102 SHEET 7 D 7 VAL B 146 ASP B 149 -1 N GLU B 147 O THR B 154 SHEET 1 E 2 LYS B 122 VAL B 123 0 SHEET 2 E 2 THR B 140 TYR B 141 1 O THR B 140 N VAL B 123 LINK C ILE A 105 N CSO A 106 1555 1555 1.34 LINK C CSO A 106 N ALA A 107 1555 1555 1.34 CISPEP 1 GLY A 65 PRO A 66 0 -3.75 CISPEP 2 GLY B 65 PRO B 66 0 -6.22 CRYST1 141.880 41.831 63.344 90.00 115.79 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007048 0.000000 0.003406 0.00000 SCALE2 0.000000 0.023906 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017533 0.00000